Flow-dependent nanodrug targeting for atherosclerosis prevention
Cardiovascular Research · 22.05.2026 · 122 (7) · 801-802
DOI: 10.1093/cvr/cvag079 ↗Kurz gefasst
Editorial in der Zeitschrift Cardiovascular Research, online erschienen am 20.04.2026. Verfasst von Tanveer A Tabish und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine, Radcliffe Department of Medicine, British Heart Foundation (BHF) Centre of Research Excellence, University of Ox…. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: British Heart Foundation (BHF), Wellcome Trust Award, Oxford BHF Centre of Research Excellence.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Division of Cardiovascular Medicine, Radcliffe Department of Medicine, British Heart Foundation (BHF) Centre of Research Excellence, University of Oxford, Oxford OX3 7BN, UK.
- School of Cardiovascular and Metabolic Health, University of Glasgow, Glasgow, UK.
ORCID-Profile: Tanveer A Tabish, Craig A Lygate
Förderung
- British Heart Foundation (BHF)
- Wellcome Trust Award
- Oxford BHF Centre of Research Excellence
- BHF
Zitieren
APA
Tabish, T. A., & Lygate, C. A. (2026). Flow-dependent nanodrug targeting for atherosclerosis prevention. Cardiovascular Research, 122(7), 801-802. https://doi.org/10.1093/cvr/cvag079
Vancouver
Tabish TA, Lygate CA. Flow-dependent nanodrug targeting for atherosclerosis prevention. Cardiovascular Research. 2026;122(7):801-802. doi:10.1093/cvr/cvag079
BibTeX
@article{Tabish2026,
author = {Tabish, Tanveer A and Lygate, Craig A},
title = {Flow-dependent nanodrug targeting for atherosclerosis prevention},
journal = {Cardiovascular Research},
year = {2026},
volume = {122},
number = {7},
pages = {801--802},
doi = {10.1093/cvr/cvag079}
}
EUVIMED